12th Annual NATA Symposium
Scientific Program
Thursday, April 7, 2011
MORNING
8:45-9:00 Welcome Addresses
William Murphy, Dublin, Ireland
Philippe Van der Linden, Brussels, Belgium
BLOOD SAFETY: NEW PATHOGENS AND THEIR INACTIVATION
Marcela Contreras, London, UK
William Murphy, Dublin, Ireland
9:00-9:20 How Safe Is Blood? An Overview
René P. de Vries, Leiden, The Netherlands
9:20-9:40 New Pathogens – What’s Out There?
Alan Kitchen, London, UK
9:40-10:00 Pathogen Inactivation in 2011
William Murphy, Dublin, Ireland
10:00-10:30 Questions and Answers
10:30-11:00 Break
FLUID THERAPY IN THE OPERATING ROOM AND IN THE INTENSIVE CARE UNIT
Konrad Messmer, Munich, Germany
Oliver Habler, Frankfurt, Germany
11:00-11:20 Monitoring the Effectiveness of Fluid Therapy: Volume vs. Oxygen Delivery
Benoit Vallet, Lille, France
11:20-11:40 The Ideal Fluid in The Operating Room: What Is The Evidence?
Philippe Van der Linden, Brussels, Belgium
11:40-12:00 The Ideal Fluid in The Intensive Care Unit: What Is The Evidence?
Jean-Louis Vincent, Brussels, Belgium
12:00-12:30 Questions and Answers
WORKSHOP: POINT-OF-CARE COAGULATION MONITORING: TEG, ROTEM
Pär I. Johansson, Copenhagen, Denmark
Alastair F. Nimmo, Edinburgh, UK
11:00-12:30 (Maximum 25 participants)
WORKSHOP: INTERACTIVE CASE SCENARIO: MANAGEMENT IN TRAUMA
Karim Brohi, London, UK
Herbert Schöchl, Vienna, Austria
11:00-12:30 (Maximum 25 participants)
12:30-14:30 Lunch Break, Satellite Symposia
LUNCHTIME SATELLITE SYMPOSIUM: MANAGEMENT OF PERIOPERATIVE BLEEDING
Supported by an educational grant from CSL Behring
Oliver Habler, Frankfurt, Germany
12:45-12:50 Introduction
Oliver Habler, Frankfurt, Germany
12:50-13:10 ”Theranostic” – A New Strategy in Guiding Hemostatic Drugs?
Benny Sørensen, London, UK
13:10-13:30 FFP – The Best Choice to Manage Bleeding?
Sibylle Kozek-Langenecker, Vienna, Austria
13:30-13:50 Trauma – Goal-Directed Coagulation Management
Herbert Schöchl, Vienna, Austria
13:50-14:15 Discussion
LUNCHTIME SATELLITE SYMPOSIUM: ADVANCES IN INTRAVENOUS IRON THERAPY – BENEFITS FOR SURGICAL AND CANCER PATIENTS
Supported by an educational grant from Vifor Pharma
Alice Maniatis, Athens, Greece
12:45-12:50 Introduction
Alice Maniatis, Athens, Greece
12:50-13:10 Novel Intravenous Iron Preparations – Which Benefits for Which Patients?
Iain C. Macdougall, London, UK
13:10-13:30 Intravenous Iron and Surgical Patient Blood Management
Toby Richards, London, UK
13:30-13:50 Intravenous Iron and Management of Cancer-Related Anemia
Pere Gascøn, Barcelona, Spain
13:50-14:15 Q&A and Roundtable Discussion
Thursday, April 7, 2011
AFTERNOON
BLOOD MANAGEMENT IN MASSIVELY BLEEDING PATIENTS
Charles-Marc Samama, Paris, France
Jean-François Hardy, Montreal, QC, Canada
14:30-14:50 Acute Traumatic Coagulopathy
Karim Brohi, London, UK
14:50-15:10 Red Blood Cells, Fresh Frozen Plasma and Platelets Should Be Administrated in a 1:1:1 Ratio: PRO
Pär I. Johansson, Copenhagen, Denmark
15:10-15:30 Red Blood Cells, Fresh Frozen Plasma and Platelets Should Be Administrated in a 1:1:1 Ratio: CON
Herbert Schöchl, Vienna, Austria
15:30-16:00 Questions and Answers
WORKSHOP: INTRAVENOUS IRON THERAPY
Alice Maniatis, Athens, Greece
Manuel Muñoz, Málaga, Spain
14:30-16:00 (Maximum 25 participants)
WORKSHOP: USE OF AUTOLOGOUS BLOOD IN ORTHOPEDIC SURGERY
Dafydd Thomas, Swansea, Wales, UK
Nadia Rosencher, Paris, France
14:30-16:00 (Maximum 25 participants)
16:00-16:30 Break
BEST POSTERS’ PRESENTATION
Jean-François Hardy, Montreal, QC, Canada
Alice Maniatis, Athens, Greece
16:30-16:45 Randomised Controlled Trial on Erythropoietin and Blood Salvage as Transfusion Alternatives in Orthopedic Surgery Using a Restrictive Transfusion Policy
Cynthia So-Osman, Leiden, The Netherlands
16:45-17:00 The Degree of Postoperative Anemia Is Not Related to Orthostatic Intolerance During Early Mobilization After Total Hip Arthroplasty
Øivind Jans, Copenhagen, Denmark
17:00-17:15 Massive Transfusion Protocol Is Not Associated With a Reduced Risk of Early Coagulopathy
Laurie Lafontaine, Montreal, QC, Canada
17:15-17:30 Neopterin Levels Confirm Immunostimulation by Unwashed Salvaged Blood Transfusion
Nahidul Islam, Tralee, Ireland
17:45-18:30 NATA General Assembly
Friday, April 8, 2011
MORNING
BREAKING NEWS
Philippe Van der Linden, Brussels, Belgium
Jeffrey L. Carson, New Brunswick, NJ, USA
9:00-9:20 Postoperative Anemia in Orthopedic Patients – TRIOS Study
Jean-François Hardy, Montreal, QC, Canada
9:20-9:40 NATA Benchmark Study
Hans Gombotz, Linz, Austria
9:40-10:00 Tranexamic Acid in Trauma – CRASH-2 Study
Marcel Levi, Amsterdam, The Netherlands
10:00-10:30 Questions and Answers
10:30-11:00 Break
BLOOD MANAGEMENT IN ORTHOPEDIC SURGERY
Manuel Muñoz, Málaga, Spain
Dafydd Thomas, Swansea, Wales, UK
11:00-11:20 Transfusion Triggers in Orthopedic Patients
Jeffrey L. Carson, New Brunswick, NJ, USA
11:20-11:40 Preoperative Management of Anemic Patients Coming for Major Orthopedic Surgery
Nadia Rosencher, Paris, France
11:40-12:00 Transfusion Alternatives in Orthopedic Patients
Oliver Habler, Frankfurt, Germany
12:00-12:30 Questions and Answers
WORKSHOP: POINT-OF-CARE COAGULATION MONITORING: TEG, ROTEM
Pär I. Johansson, Copenhagen, Denmark
Alastair F. Nimmo, Edinburgh, UK
11:00-12:30 (Maximum 25 participants)
WORKSHOP: INTERACTIVE CARE SCENARIO: BLOOD MANAGEMENT IN TRAUMA
Karim Brohi, London, UK
Herbert Schöchl, Vienna, Austria
11:00-12:30 (Maximum 25 participants)
12:30-14:30 Lunch Break
Friday, April 8, 2011
AFTERNOON
PERIOPERATIVE MANAGEMENT OF NEW ANTIPLATELETS AGENTS
Hans Gombotz, Linz, Austria
Charles-Marc Samama, Paris, France
14:30-14:50 Antiplatelets Agents: Old, New, and Monitoring Their Effect
Pierre-Guy Chassot, Lausanne, Switzerland
14:50-15:10 Patients with Stenting: To Stop or Not To Stop Antiplatelet Therapy? Bridging: When and How?
Charles-Marc Samama, Paris, France
15:10-15:30 Risk and Management of Bleeding in Patients on Antiplatelet Therapy
Pär I. Johansson, Copenhagen, Denmark
15:30-16:00 Questions and Answers
WORKSHOP: INTRAVENOUS IRON THERAPY
Alice Maniatis, Athens, Greece
Manuel Muñoz, Málaga, Spain
14:30-16:00 (Maximum 25 participants)
WORKSHOP: USE OF AUTOLOGOUS BLOOD IN ORTHOPEDIC SURGERY
Dafydd Thomas, Swansea, Wales, UK
Nadia Rosencher, Paris, France
14:30-16:00 (Maximum 25 participants)
16:00-16:30 Break
THROMBOPROPHYLAXIS IN 2011
Jean-François Hardy, Montreal, QC, Canada
16:30-16:50 Thromboprophylaxis: for Whom, When and How?
Charles-Marc Samama, Paris, France
16:50-17:10 Management of the Bleeding Patient on Thromboprophylaxis
Marcel Levi, Amsterdam, The Netherlands
17:10-17:30 Questions and Answers
